People · Operator
Named in public records as an officer, director or promoter · active 2020–2020 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Q-State Holdings, Inc. | — | Biotechnology | Series C | $86.1M | $869.1M | 2020 |
Michael LaCascia at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael LaCascia on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Fleming | 1 | 9 |
| Andrew Ross | 1 | 4 |
| Jonathan Thomas | 1 | 4 |
| Matthew Fox | 1 | 2 |
| David Margulies | 1 | 2 |
| David Knudson | 1 | 2 |
| Steven Hyman | 1 | 2 |
| Mark Evenstad | 1 | 2 |
| Matthew Might | 1 | 1 |
| Dave Knudson | 1 | 1 |
| Chad Martinson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.